Clinical Trial Update: Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating gemcitabine, docetaxel, and hydroxychloroquine for recurrent or refractory osteosarcoma; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Osteosarcoma, Refractory Osteosarcoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING